Prediction of Chemotherapeutic Efficacy in Non-Small Cell Lung Cancer by Serum Metabolomic Profiling. [electronic resource]
Producer: 20191114Description: 2100-2109 p. digitalISSN:- 1557-3265
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Biomarkers -- blood
- Carcinoma, Non-Small-Cell Lung -- blood
- Chromatography, Liquid
- Computational Biology
- Female
- Humans
- Lung Neoplasms -- blood
- Male
- Metabolome
- Metabolomics -- methods
- Prognosis
- ROC Curve
- Reproducibility of Results
- Tandem Mass Spectrometry
- Treatment Outcome
- Workflow
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.